Positron emission tomography can be used to study biochemical reactions in the living human body. The techniques applied are described in some detail for normal and pathological conditions of brain and heart. The injection of short lived radiopharmaceutical preparations containing isotopes of common elements allows the visualisation of biochemical reactions and their progress to be followed in space and time.
Get full access to this article
View all access options for this article.
References
1.
BaronJ. C., BousserM. G., ReyA., et al.: ‘Reversal of focal “misery-perfusion syndromy” by extra-intracranial arterial bypass in hemodynamic cerebral ischemia’, Stroke, 1981, 12, 454–459.
2.
De LeonM., FerrisS. H., GeorgeA. E., et al.: ‘Regional correlation of PET and CT in senile dementia of the Alzheimer type’, AJNR, 1983, 4, 553–556.
3.
Di ChiroG., De La PazR. L., BrooksR. A., SokoloffL., KornblithP. L., SmithB. A., PatronasN. J., KufiaC. V., KesslerR. M., JohnsonG. S., ManningR. G., and WolfA. P.: ‘Glucose utilization of cerebral gliomas measured by [18F]fluorodeoxyglucose and positron emission tomography’, Neurology, 1982, 32, 1323–1329.
4.
EngelJ.Jr, KuhlD. E. and PhelpsM. E.: ‘Patterns of human local cerebral glucose metabolism during epileptic cesures’, Science, 1982, 218, 64–66.
5.
FeinendegenL. E. and HerzogH.: ‘Biochemistry of the BBB with respect to functional analysis by PET. Radiopharmaceuticals and brain pathology studied with PET and SPECT’, (ed. DiksicM., et al.), Chap. 7, 119–133; 1991, Boca Raton, FL, CRC Press.
6.
FeinendegenL. E., HerzogH., WielerH., PattonD. D. and SchmidA.: ‘Glucose transport and utilization in the human brain: model using carbon-11-methyl-glucose and positron emission tomography’, J. Nucl. Med., 1986, 27, 1867–1877.
7.
FrackowiakR. S. J., LenziG. L., JonesT. and HeatherJ. D.: ‘Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 15O and positron emission tomography: filory, procedure and normal values’, J. Comput. Assist. Tomogr., 1980, 46, 727–736. E. S. Garnett, C. Nahmias and G. Firnau: ‘Dopamine visualized in the basal ganglia of living man’, Nature, 1984, 305, 137–138.
8.
HenrichM. M., VesterE., Von der loheE., HerzogH, SimonH., KuikkaJ. T. and FeinendegenL. E.: ‘The comparison of 2-18F-2-deoxyglucose and 15-(ortho-123I-phenyl)-pentadecanoic acid uptake in persisting defects on thallium-201 tomography in myocardial infarction’, J. Nucl. Med., 1991, 32, 1353–1357.
9.
HerzogH., LamprechtA., KühnA., RodenW., VosteenK.-H. and FeinendegenL. E.: ‘Cortical activation in profoundly deaf patients during cochlear implant stimulation demonstrated by H215O PET’, J. Comput. Assist. Tomogr., 1991, 15, 369–375.
10.
HerzogH., LeleV. R., KuwertT., LangenK.-J., Rota kopsE. and FeinendegenL. E.: ‘Cerebral glucose consumption and transcendental meditation’, Neuropsychobiology, 1990, 23, 182–187.
11.
KuhlD. E., PhelpsM. E., KowellA. P., MetterE. J., SelinC., and WinterJ.: ‘Mapping local metabolism and perfusion in normal and ischemic brain by emission computed tomography of 18FDG and 13NH3’, Ann. Neurol., 1980, 8, 47–60.
12.
KuwertT., HefterH., ScholzD., MilzM., WeissP., ArendtG., HerzogH., LokenM., HennericiM. and FeinendegenL. E.: ‘Regional cerebral glucose consumption measured by positron emission tomography in patientswith Wilson's disease’, Eur. J. Nucl. Med., 1992, 19, 96–101.
13.
KuwertT., HennericiM., LangenK.-j., AulichA, HerzogH., SitzerM. and FeinendegenL. E.: ‘Cerebral glucose consumption measured PET in patients with thalamic infarction’, Cerebrovasc. Dis., 1991, 1, 327–336.
14.
KuwertT., HennericiM., LangenK.-J., RotakopsE., AulichA, RautenbergW. and FeinendegenL. E.: ‘Compensatory mechanisms in patients with asymptomatic carotid artery occlusion’, Neurol. Res., 1990, 12, 89–93.
15.
KuwertT., LangeH. W., LangenK.-J., HerzogH., AulichA. and FeinendegenL. E.: ‘Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease’, Brain, 1990, 113, 1405–1423.
16.
LangenK.-J., RoosenN, KuwertT., HerzogH, KiwitJ. C. W., RotakopsE., MuzikO, BöckW. J., and FeinendegenL. E.: ‘Early effects of intraarterial chemotherapy in patients with brain tumours studied with PET. Preliminary results’, Nucl. Med. Comm., 1989, 10, 779–790.
17.
LenziG., FrackowiakR. S. and JonesT.: ‘Cerebral oxygen metabolism and blood flow in human cerebral ischemic infarction’, J. Cereb. Blood Flow Metab., 1982, 2, 321–335.
18.
MazziottaJ. C., PhelpsM. E. and CarsonR. E.: ‘Tomographic mapping of human cerebral metabolism: Subcortical responses to auditory and visual stimulation’, Neurology, 1984, 34, 825–828.
19.
PhelpsM. E., HuangS. C., HoffmanE. J., SelinC., SokoloffL., and KuhlD. E.: ‘Tomographic measurement of local cerebral glucose metabolic rate in humans with (18F)2-fluoro-2-deoxyglucose: validation of method’, Ann. Neurol., 1979, 6, 371–388.
20.
PowersW. J., MartinW. R., HerscovitchP., RaichleM. E. and GrubbR. L.: ‘Extracranial-intracranial bypass surgery: hemodynamic and metabolic defects’, Neurology, 1984, 34, 1168–1174.
21.
ReivichM., KuhlD. E., WolfA., GreenbergJ., PhelpsM. E., IdoT., CasellaV., FowlerJ., HoffmanE., AlaviA., SomP. and SokoloffL.: ‘[18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man’, Circ. Res., 1979, 44, 127–137.
22.
SchelbertH. R., WisenbergG., PhelpsM. E., et al.: ‘Noninvasive assessment of coronary stenosis by myocardial imaging during pharmacologic vasodilation. VI: Detection of coronary artery disease in man with intravenous N-13 ammonia and positron computed tomography’, Am. J. Cardiol., 1982, 49, 1197–1207.
23.
SokoloffJ., ReivichM., KennedyC., DesrosiersM. H., PatlakC. S., PettigrewK. D., SakuradaO. and ShinoharaM.: ‘The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure and normal values in the contious and anasthous protized albino rat’, J. Neurochem., 1977, 28, 897–916.
24.
StraussL. G., CloriusJ. H., LehnerB., SchlagP., HelusF., SchmidlinP., KüblerW., PortR., ChenL. and LorenzW. J.: ‘18F-Uracil accumulation in liver metastases after i.v. and i.a. tracer injection’, J. Nucl. Med., 1988, 29, (suppl.), 776.
25.
WielerH., HerzogH., LangenK.-J., SchmidA., RotaE. and FeinendegenI. E.: ‘Jahrbuch der Radiologie 1987, Regensberg und Biermann, aus Wissenschaft und Klinik’, (ed. GockelH. P.), 49–70; 1987, Münster, Wissenschaftliche Verlagsgesellschaft Regensburg und Biermann mbH.
26.
WielerH., HerzogH., PattonD. D., SchmidA., RotaE. and FeinendegenL. E.: Med. Prog. Technol., 1986, 11, 73–106.
